Andy Blauvelt, MD, MBA: Safety Data on JAK Inhibitors for Atopic Dermatitis

Dr. Blauvelt discusses his presentation at Maui Derm 2023, in which he compares new safety data for JAK inhibitors in atopic dermatitis treatment with data from older JAK inhibitors historically used for other diseases.

More Maui Derm 2023 Video Coverage

Dr. Zirwas reviews new advancements in systemics for atopic dermatitis including JAK inhibitors and the current black box warnings for these treatments....